News - sildenafil


Current filters:


Popular Filters

Actelion says COMPASS-2 bosentan study fails primary endpoint

Actelion says COMPASS-2 bosentan study fails primary endpoint


Europe’s largest biotech company Actelion has announced disappointing results of COMPASS-2, a Phase…

ActelionBiotechnologybosentanPfizerResearchRespiratory and PulmonarysildenafilTracleer

Teva and Actavis debut generic Viagra in Europe


The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

New Zealand updates on Tracleer and sildenafil listing


New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

ActelionArrow PharmaceuticalsAsia-PacificPharmaceuticalPricingRegulationRespiratory and PulmonarysildenafilTracleer

FDA warns against use of Pfizer's Revatio in children with PAH


The US Food and Drug Administration is recommending that Revatio (sildenafil), marketed by US drugs behemoth…

North AmericaPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatiosildenafil

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top